IHE´s Board of Directors – New member
By annette
We are happy to announce that Jenni Nordborg – Director of International Affairs at Lif – The research-based pharmaceutical industri – joins our Board of Directors Read more about Jenni Nordborg
IHE - The Swedish Institute for Health Economics
IHE´s Board of Directors – New member
New report – Evaluation, introduction and reimbursement of new therapies against rare diagnoses
By annette
In this IHE report the author Ulf Persson, senior advisor at IHE, has identified a number of conditions which lead to the fact that today’s methods of valuing medicines hardly lead us to a satisfactory understanding of the value of orphan medicines. The insurance value, the value of hope and process-related benefits are not included. …
IHE participates at SMDM 2023 in Berlin
By annette
Michael Willis from IHE will participate in two workshops at SMDM-Society for Medical Decision Making, May 21-23 in Berlin. Issue Panel 1C: Proving health economics models are valid – why, how and who? Chair: Talitha Feenstra (National Institute for Public Health and the Environment (RIVM), Netherlands) Panelists: Amanda Adler, University of Oxford, UK Xavier Pouwels, …
New IHE Report – Breast cancer
By annette
New IHE Report about challenges and opportunities to improve the care of women with triple-negative breast cancer in Asia-Pacific. Read more and download the report
IHE participates at ISPOR in Boston 7-10 May
By annette
IHE participates at the conference with a poster presentation on the importance of considering price metrics and market dynamics in US economic evaluation, using the case of SGLT-2 inhibitors in the treatment of T2D. Michael Willis from IHE will also moderate a workshop, “Addressing Heterogeneity in Comparative Economic Analysis in the Decentralized US Setting: Are …
IHE presents at breast cancer conference on May 5 in Singapore
By annette
The Swedish Institute for Health Economics participates at the 11th Asia-Pacific Breast Cancer Summit 2023 on May 4-6, 2023 in Singapore. Thomas Hofmarcher will present findings of an upcoming policy report on triple-negative breast cancer (TNBC) in the Asia-Pacific region. He will highlight the health-economic impact of TNBC on patients and society as well as …
IHE will participate in the European network PRIME-ROSE
By annette
PRIME-ROSE is a precision cancer medicine trial network and implementation initiative.The PRIME-ROSE vision is access to affordable precision cancer medicine that prolongs life at the best quality possible for all cancer patients. Read more
The I3LUNG project – Posterpresentation at SHEA 2023
By annette
We are happy to announce that Dr Michael Willis from IHE is presenting a poster at this year’s annual meeting of the Swedish Health Economic Association (SHEA). The poster presents results from a literature review and assessment of published budget impact models (BIMs) for NSCLC. BIMs are an important basis for decision-making and should be …
New publication – High use of pain, depression and anxiety drugs in hemophilia
By annette
The prevalence of pain has long been focused in haemophilia research but depression and anxiety are less studied. A Nordic collaboration has investigated national prescription drug data in more than 3000 Nordic persons with haemophilia and compared data patterns to population controls. The key study finding is a persistently higher use of pain, depression and …
Newly published
By annette
Diabetes Two studies focusing on people with type 2 diabetes and established cardiovascular disease (eCVD) in Sweden have been published in the medical journal “Diabetes, Obesity and Metabolism”. The first study examines the burden of hospital-based care, work absence, associated costs and excess mortality in people with type 2 diabetes, with and without eCVD. The …